July 20 (Reuters) - Johnson & Johnson (NYSE:JNJ) JNJ.N :
* Health Canada approves INVOKAMET for treatment of adults with type 2 diabetes Source text for Eikon: ID:nCNWhrq2Fa Further company coverage: JNJ.N
(Bengaluru Newsroom : +1-646-223-8780)
July 20 (Reuters) - Johnson & Johnson (NYSE:JNJ) JNJ.N :
* Health Canada approves INVOKAMET for treatment of adults with type 2 diabetes Source text for Eikon: ID:nCNWhrq2Fa Further company coverage: JNJ.N
(Bengaluru Newsroom : +1-646-223-8780)